FindTrial
Sign In

Experimental group will receive Herbal Drink 250 cc PO QID on day 1 to day 7 and Favipiravir group will receive Favipiravir treatment of 1800 mg PO BID on day 1, then 800 mg PO BID from day 2 to day 5

3 trials

Sponsors

Giving Mind Nirvana Soul Foundation

Conditions

confirmed RT-PCR for SAR-CoV-2 patients with mild to moderate symptoms mild-symptom covid-19 patients, moderate-symptom covid-19 patients, Herbal Drink, Favipiravir, viral clearanceconfirmed RT-PCR for SAR-CoV-2 patients with mild to severe symptoms mild-symptom covid-19 patients, moderate-symptom covid-19 patients, severe-symptom covid-19 patients, Herbal Drink, Favipiravir, viral clearanceconfirmed RT-PCR for SAR-CoV-2 patients with moderate symptoms moderate-symptom covid-19 patients, Herbal Drink, Favipiravir, viral clearance

Phase 2

Efficacy and safety of Herbal Drink in mild to moderate Covid-19 patients: pilot study
Active, not recruitingTCTR20211220001
Giving Mind Nirvana Soul Foundationconfirmed RT-PCR for SAR-CoV-2 patients with mild to moderate symptoms mild-symptom covid-19 patients, moderate-symptom covid-19 patients, Herbal Drink, Favipiravir, viral clearance
Start: 2021-12-21Target: 100Updated: 2026-03-30
Efficacy and safety of Herbal Drink in moderate COVID-19 patients: pilot study
Active, not recruitingTCTR20220125001
Giving Mind Nirvana Soul Foundationconfirmed RT-PCR for SAR-CoV-2 patients with moderate symptoms moderate-symptom covid-19 patients, Herbal Drink, Favipiravir, viral clearance
Start: 2022-01-24Target: 100Updated: 2026-03-30
Efficacy and safety of Herbal Drink in mild to severe COVID-19 patients: pilot study
Active, not recruitingTCTR20220204005
Giving Mind Nirvana Soul Foundationconfirmed RT-PCR for SAR-CoV-2 patients with mild to severe symptoms mild-symptom covid-19 patients, moderate-symptom covid-19 patients, severe-symptom covid-19 patients, Herbal Drink, Favipiravir, viral clearance
Start: 2022-01-26Target: 100Updated: 2026-03-30